You're looking at it in the wrong way imo. Before the announcement, the stock was trading at 80c for a AUD$130 million market cap. It has added 50% since the announcement or AUD$66 million. So where you say that 2/3 of the current market cap (AUD$126 million) is linked to the most recent news, the market only assigns 1/3 of the market cap to the news (AUD$66 million).
I do however agree that the deal is worth more than the AUD$66 million added in market cap as it completely derisks the story and it now presents a low risk way to play the Alzheimer story as it will benefit from ongoing clinical research / trials, ALZ commercialization, etc.
Putting numbers on it, page-4
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
-0.015(1.60%) |
Mkt cap ! $157.9M | |||
| Open | High | Low | Value | Volume |
| 92.5¢ | 95.0¢ | 91.5¢ | $157.5K | 170.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3377 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.5¢ | 246 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| CGS (ASX) Chart |